| 发明名称 |
Treatment of sanfilippo syndrome type b |
| 摘要 |
<p>Disclosed is a stable formulation comprising a recombinant alpha-N-acetyl-glucosaminidase (Naglu) protein at a concentration at or greater than 5 mg/ml, and wherein the formulation comprises no greater than 50 mM of phosphate.</p> |
| 申请公布号 |
NZ605871(A) |
申请公布日期 |
2015.02.27 |
| 申请号 |
NZ20110605871 |
申请日期 |
2011.06.25 |
| 申请人 |
SHIRE HUMAN GENETIC THERAPIES INC |
发明人 |
CONCINO MICHAEL F.;HOLMES KEVIN;MARTINI PAOLO;ROMASHKO ALLA;MEIYAPPAN MUTHURAMAN;ZHANG BOHONG;ISKENDERIAN ANDREA;LUNDBERG DIANNA;NORTON ANGELA;STRACK-LOGUE BETTINA;HUANG YAN;ALESSANDRINI MARY;CALIAS PERICLES;PAN JING;PFEIFER RICHARD |
| 分类号 |
A61K38/47;A61P25/00;A61P25/28 |
主分类号 |
A61K38/47 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
